BCL2 and osteosarcoma: Ginsenoside Rh2 can affect the expression of apoptotic proteins such as Bcl-2 in osteosarcoma (U-2 OS) and esophageal cancer (ECA109 and TE-13) cells, thereby inhibiting tumor progression [665, 666].